Development of pyrimidine-based inhibitors of Janus tyrosine kinase 3
摘要:
A new class of pyrimidine-based Janus tyrosine kinase 3 (JAK3) inhibitors are described. Many of these inhibitors showed low nanomolar activity against JAK3. (c) 2006 Elsevier Ltd. All rights reserved.
Development of pyrimidine-based inhibitors of Janus tyrosine kinase 3
作者:Jack J. Chen、Kumar D. Thakur、Michael P. Clark、Steven K. Laughlin、Kelly M. George、Roger G. Bookland、Jan R. Davis、Edward J. Cabrera、Vijay Easwaran、Biswanath De、Y. George Zhang
DOI:10.1016/j.bmcl.2006.08.022
日期:2006.11
A new class of pyrimidine-based Janus tyrosine kinase 3 (JAK3) inhibitors are described. Many of these inhibitors showed low nanomolar activity against JAK3. (c) 2006 Elsevier Ltd. All rights reserved.
<i>S</i>(+)-4-(1-Phenylethylamino)quinazolines as Inhibitors of Human Immunoglobuline E Synthesis: Potency Is Dictated by Stereochemistry and Atomic Point Charges at N-1
found in the reporter gene assay with those measured by IgE-ELISA in primary human splenocytes provided evidence that the blockade of IgE synthesis is the direct consequence of IgE-germline gene inhibition, thereby validating the reporter gene assay. Parallel synthesis in solution rapidly provided a series of analogues of compound 1 with modifications in the phenethylamine side chain and the quinazoline